12.29
0.16%
0.02
Finanzdaten der Bioventus Inc-Aktie (BVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-30 | 2023-12-31 | 2023-09-30 | 2023-07-01 | 2023-04-01 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
4.41%
129.46
|
135.42 | 120.79 | 137.07 | 119.06 |
Cost Of Revenue |
16.38%
41.08
|
49.12 | 41.94 | 47.95 | 45.14 |
Gross Profit |
2.41%
88.38
|
86.30 | 78.85 | 89.12 | 73.92 |
Operating Expenses
|
2.45%
83.05
|
85.14 | 76.43 | 82.37 | 165.98 |
Benefits Costs and Expenses |
6.46%
134.53
|
143.83 | 128.99 | 141.42 | 219.22 |
Costs And Expenses |
6.46%
134.53
|
143.83 | 128.99 | 141.42 | 219.22 |
Depreciation and Amortization |
16.51%
1.755
|
2.102 | 2.317 | 2.294 | 2.129 |
Operating Income/Loss |
357.25%
5.327
|
1.165 | 2.418 | 6.75 | -92.06 |
Nonoperating Income/Loss |
8.68%
-10.40
|
-9.571 | -10.61 | -11.10 | -8.106 |
Income/Loss From Continuing Operations Before Tax |
39.63%
-5.075
|
-8.406 | -8.191 | -4.35 | -100.16 |
Income Tax Expense/Benefit |
220.93%
0.907
|
-0.75 | 0.60 | 0.381 | -0.146 |
Income/Loss From Continuing Operations After Tax |
21.87%
-5.982
|
-7.656 | -8.791 | -4.731 | -100.02 |
Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | -74.43 |
Net Income/Loss
|
21.87%
-5.982
|
-7.656 | -8.791 | -4.731 | -174.45 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
9.49%
-1.412
|
-1.56 | -1.488 | -1.05 | -20.36 |
Basic Average Shares |
41,361%
63.38
|
0.1529 | 62.82 | 62.55 | 62.12 |
Diluted Average Shares |
41,361%
63.38
|
0.1529 | 62.82 | 62.55 | 62.12 |
Basic Earnings Per Share |
22.22%
-0.07
|
-0.09 | -0.12 | -0.06 | -2.24 |
Diluted Earnings Per Share |
22.22%
-0.07
|
-0.09 | -0.12 | -0.06 | -2.24 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):